Ascoli Piceno’s Oncology unit Sets New Benchmarks in Cancer Care for 2024
In 2024, the Complex Operating Unit of Medical Oncology under the Territorial Health Authority (AST) of Ascoli achieved remarkable milestones in cancer care, demonstrating a steadfast commitment to patient well-being. Between the hospitals of Ascoli and San Benedetto, the unit recorded 1,040 hospitalizations in Day hospital settings, totaling 18,242 days of hospitalization. Additionally, 7,500 outpatient services were provided throughout the year, showcasing the unit’s dedication to comprehensive care.
A notable highlight of the year was the increased participation in Free Oncological Screening Programs offered by the National Health Service. Mammographic screening saw a rise from 36.24% to 42%, cervical screening increased from 34.31% to 41.5%, and colorectal screening jumped from 20.18% to 31%. This surge in participation was made possible by the AST’s expanded appointment offerings, ensuring greater accessibility to preventive care.On february 4, the world observed World Cancer Day, a global initiative promoted by the Union for International Cancer Control and supported by the World Health Institution. The theme for 2024, “United by Unique,” emphasized the importance of placing individuals and their unique stories at the heart of cancer care. Francesca Chiara Giorgi, Director of the AST’s Oncology Unit, eloquently captured the essence of this theme: “Each patient has unique needs and perspectives, but all those who face cancer—patients, family members, and health personnel—are united by the desire to overcome the disease and live better. cancer is not only a medical diagnosis but a reality that deeply involves people’s lives, generating suffering but also resilience and hope.”
The Medical oncology Unit of the AST follows approximately 1,000 new patients annually, many of whom undergo specialized treatments such as chemotherapy, immunotherapy, and targeted biological therapies. The unit’s approach goes beyond treating the disease; it focuses on seeing the person behind the diagnosis. This philosophy is reinforced through collaborations with voluntary associations like Iom and Bianco Airone, which provide invaluable support to patients and their families throughout their care journey.
The AST’s efforts in 2024 underscore its unwavering commitment to enhancing cancer prevention and care in the Piceno territory. By increasing access to screening programs and prioritizing personalized patient care, the unit has set a new standard for oncology services.
Key Achievements of the AST Oncology Unit in 2024
| Metric | 2024 Data |
|———————————|—————————–|
| day Hospital Hospitalizations | 1,040 |
| Total Hospitalization Days | 18,242 |
| Outpatient Services Provided | 7,500 |
| Mammographic Screening Uptake | 36.24% → 42% |
| Cervical Screening Uptake | 34.31% → 41.5% |
| Colorectal Screening Uptake | 20.18% → 31% |
The AST’s achievements in 2024 are a testament to its dedication to improving cancer care and prevention. by focusing on personalized care and expanding access to screening, the unit has made significant strides in addressing the unique needs of its patients.
Ascoli Piceno’s Oncology Unit Sets New Benchmarks in Cancer Care for 2024
In 2024, the Complex Operating Unit of Medical Oncology under the Territorial Health Authority (AST) of Ascoli achieved remarkable milestones in cancer care, demonstrating a steadfast commitment to patient well-being. Between the hospitals of Ascoli and San Benedetto, the unit recorded 1,040 hospitalizations in Day hospital settings, totaling 18,242 days of hospitalization. Additionally, 7,500 outpatient services were provided throughout the year, showcasing the unit’s dedication to comprehensive care. We sat down with Dr. Francesca Chiara Giorgi, Director of the AST’s Oncology Unit, to discuss these achievements and their impact on cancer prevention and treatment.
1. Increased Participation in Screening Programs
Editor: Dr. Giorgi, one of the standout achievements in 2024 was the significant increase in participation rates for oncological screening programs. Could you elaborate on how this was achieved?
Dr. Giorgi: Absolutely. We focused on making screenings more accessible by expanding appointment offerings and improving outreach efforts. For instance, mammographic screening rates rose from 36.24% to 42%, cervical screening increased from 34.31% to 41.5%, and colorectal screening jumped from 20.18% to 31%. These efforts were supported by collaborations with local organizations and community awareness campaigns, ensuring that more individuals could benefit from early detection.
2. Personalized Cancer Care approach
Editor: Your unit is known for its emphasis on personalized care. How does this approach impact patient outcomes?
Dr. Giorgi: Personalized care is at the heart of our philosophy. We treat approximately 1,000 new patients annually, many of whom undergo specialized treatments like chemotherapy, immunotherapy, and targeted biological therapies. By focusing on the individual—understanding their unique needs, circumstances, and perspectives—we can tailor treatments more effectively. This not only improves clinical outcomes but also enhances the overall quality of life for our patients. It’s about seeing the person behind the diagnosis and addressing their holistic needs.
3. Collaboration with Voluntary Associations
Editor: Your unit works closely with voluntary associations like Iom and Bianco Airone. How do these partnerships contribute to patient care?
Dr. Giorgi: These partnerships are invaluable. Cancer is not just a medical diagnosis; it’s a reality that deeply involves patients and their families. Voluntary associations provide essential support, from emotional counseling to practical assistance, helping patients navigate their care journeys. Thay complement our medical efforts by addressing the psychosocial aspects of cancer, which are equally vital in fostering resilience and hope.
4.Impact of World Cancer Day 2024
Editor: The theme for World Cancer Day 2024 was “United by Unique.” How did this resonate with your team and patients?
Dr. Giorgi: The theme was incredibly meaningful. It emphasized the importance of placing individuals and their unique stories at the center of cancer care. For us, it reinforced our commitment to personalized care and reminded us that while cancer is a shared challenge, each patient’s journey is distinct. We used the day to highlight stories of resilience and hope, showcasing how collective efforts—from medical professionals to families and communities—can make a profound difference.
5. Future Goals for the Oncology Unit
Editor: What are your key priorities moving forward as the Director of the AST’s Oncology Unit?
Dr. Giorgi: Our primary focus remains on enhancing cancer prevention and care. We aim to further increase screening participation rates, expand our outpatient services, and continue refining our personalized care approach. Additionally, we plan to strengthen our collaborations with voluntary associations and invest in innovative treatments and technologies. Ultimately, our goal is to set new benchmarks in oncology, ensuring that every patient receives the highest standard of care.
Conclusion
The AST’s Oncology Unit has made remarkable strides in 2024, from increasing screening participation rates to delivering personalized care and fostering community collaborations. Under the leadership of Dr. Francesca Chiara Giorgi, the unit has set a new standard for cancer care, prioritizing both prevention and treatment to address the unique needs of its patients. These achievements underscore the importance of a holistic, patient-centered approach in improving outcomes and enhancing the quality of life for those affected by cancer.
